MGC13057 inhibitors are a class of chemical compounds designed to specifically target the MGC13057 protein, a lesser-studied protein believed to play a role in various cellular processes. The MGC13057 protein itself belongs to a group of proteins involved in cellular signaling pathways, particularly those that regulate processes like cell growth, division, and programmed cell death (apoptosis). The inhibitors of this protein are designed to interfere with its function by binding to key active sites or allosteric sites, leading to the disruption of downstream signaling cascades that are mediated by MGC13057. These compounds often act by preventing the protein from interacting with its natural substrates or cofactors, altering its normal biochemical activity.
Structurally, MGC13057 inhibitors can vary widely depending on the specific design goals of the compound, but many share common motifs associated with their binding efficiency to the protein target. Some inhibitors are designed to mimic the natural ligands of MGC13057, while others are engineered to induce conformational changes that impair the protein's ability to function. Researchers are particularly interested in the selectivity of these inhibitors, ensuring that they interact specifically with MGC13057 without affecting other proteins in related pathways. This selectivity is crucial for understanding the precise role of MGC13057 in cellular biology, as well as in broader systems-level interactions within the cell. The study of MGC13057 inhibitors, therefore, provides insights into fundamental biochemical processes, helping to reveal more about cellular regulation and protein function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A kinase inhibitor that can inhibit a wide range of protein kinases, possibly affecting kinase-related functions of MGC13057. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin, potentially affecting the signaling pathways regulated by MGC13057. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress cell growth and proliferation, potentially affecting pathways involving MGC13057. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can block the PI3K/Akt signaling pathway, potentially modulating pathways regulated by MGC13057. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK pathway inhibitor that can block MAP kinase signaling, potentially affecting MGC13057-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAP kinase inhibitor that may influence inflammatory responses and other pathways involving MGC13057. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which might modify stress response pathways that MGC13057 is a part of. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that can prevent the activation of MAPK/ERK, potentially altering pathways with MGC13057 involvement. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of proteins, potentially stabilizing MGC13057 if it is regulated by ubiquitination. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that can block apoptosis, potentially affecting any apoptotic processes involving MGC13057. | ||||||